Bristol Myers inks licensing deal with Janux for cancer...

2026-01-22 07:26:18 ET More on Janux Therapeutics, Bristol-Myers Squibb Company 44th Annual J.P. Morgan Healthcare Conference Bristol-Myers Squibb Company (BMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Bristol-Myers Squibb: Contrarian Buy For Dividend Hunters, Despite Mounting Growth Headwinds Microsoft in pact with Bristol Myers for AI-based early detection of lung cancer Trump unveils 'Great Healthcare Plan' to lower drug prices, premiums Read the full article on Seeking Alpha For further details see: Bristol Myers inks licensing deal with Janux for cancer therapy